Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $797.5500 (-0.27%) ($794.9600 - $797.5500) on Fri. Nov. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.03% (three month average) | RSI | 37 | Latest Price | $797.5500(-0.27%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(50%) IBB(49%) SPLV(45%) XLU(44%) XLV(42%) | Factors Impacting REGN price | REGN will decline at least -0.515% in a week (0% probabilities). ONLN(-29%) UNG(-28%) VXX(-27%) USO(-25%) XLE(-19%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.515% (StdDev 1.03%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $800.98 | 5 Day Moving Average | $799.77(-0.28%) | 10 Day Moving Average | $797.53(0%) | 20 Day Moving Average | $800.98(-0.43%) | To recent high | -5.7% | To recent low | 2.9% | Market Cap | $84.563b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |